Your session is about to expire
← Back to Search
Dried Fruit for Blood Sugar Control
N/A
Waitlist Available
Led By Cyril Kendall, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Age less than 18 years or greater than 75 years
BMI<18.5kg/m2 or >30kg/m2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This trial will test the effects of different types of dried fruit on blood sugar levels.
Who is the study for?
This trial is for adults aged 18-75 in good health, who may have diabetes or issues with blood sugar levels like hyperglycemia or hypoglycemia. It's not for those underweight or obese, younger than 18 or older than 75, on certain medications, non-compliant with procedures, or with major illnesses affecting carbohydrate metabolism.
What is being tested?
The study tests if dried fruits (raisins, sultanas, dates, apricots) can manage blood glucose better compared to white bread. It explores whether these fruits lower the body's sugar response by replacing high-GI carbs ('displacement effect') or through small doses of fructose ('catalytic' fructose effect).
What are the potential side effects?
Since this trial involves consuming dried fruit and white bread as a control food item rather than medication interventions, typical drug-related side effects are not expected. However individual responses to dietary changes may vary.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am younger than 18 or older than 75.
Select...
My BMI is either below 18.5 or above 30.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: High GI Displacement EffectExperimental Treatment1 Intervention
Participants will consume a test meal containing white bread (dose: 25g available carbohydrate) and one variety of dried fruit (dose: 25g available carbohydrate) per visit for four visits. Varieties of dried fruit include: raisins, sultanas, dates, and apricots.
Group II: Dried Fruit - Glycemic IndexExperimental Treatment1 Intervention
Participants will consume a test meal containing one variety of dried fruit (dose: 50g available carbohydrate) per visit for four visits. Varieties include raisins, sultanas, dates, and apricots.
Group III: Catalytic Fructose Dose EffectExperimental Treatment1 Intervention
Participants will consume a test meal containing white bread (dose: 50g available carbohydrate) and one variety of dried fruit (dose: 7g fructose) per visit for four visits. Varieties of dried fruit include: raisins, sultanas, dates, and apricots.
Group IV: White Bread (Control)Active Control1 Intervention
Participants will consume a test meal containing white bread (dose: 50g available carbohydrate) at three study visits.
Find a Location
Who is running the clinical trial?
Glycemia Consulting Inc.UNKNOWN
University of TorontoLead Sponsor
705 Previous Clinical Trials
1,021,541 Total Patients Enrolled
33 Trials studying Diabetes
3,831 Patients Enrolled for Diabetes
International Nut and Dried Fruit Council (INC)UNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am younger than 18 or older than 75.My BMI is either below 18.5 or above 30.I have a history of major illnesses like HIV or diabetes that could affect my sugar metabolism.I am between 18 and 75 years old and in good health.I am not on medications that could risk my safety or affect the study's results.
Research Study Groups:
This trial has the following groups:- Group 1: White Bread (Control)
- Group 2: Dried Fruit - Glycemic Index
- Group 3: Catalytic Fructose Dose Effect
- Group 4: High GI Displacement Effect
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger